Anadrol 25 is an oral anabolic-androgenic compound containing Oxymetholone, a synthetic derivative of testosterone. It is widely known for its strong anabolic properties and is often associated with rapid increases in muscle mass and strength. OriginRead More
Active Ingredient:
Oxymetholone
Dosage Strength:
25 Mg
Drug Category:
Anabolic-androgenic Steroid
Chemical Formula:
C21H32O3
Anadrol 25 is an oral anabolic-androgenic compound containing Oxymetholone, a synthetic derivative of testosterone. It is widely known for its strong anabolic properties and is often associated with rapid increases in muscle mass and strength. Originally developed for medical use in the treatment of conditions such as severe anemia and muscle-wasting disorders, Oxymetholone works by increasing red blood cell production and enhancing protein synthesis within muscle tissue. Due to its potency, even lower-strength formulations like Anadrol 25 are considered highly effective.
Key Characteristics:
| Active Ingredient | Oxymetholone |
| Dosage Strength | 25 mg |
| Drug Category | Anabolic-androgenic steroid |
| Chemical Formula | C21H32O3 |
| Molecular Weight | 332.48 g/mol |
| Chemical Classification | Dihydrotestosterone derivative |
| Administration Route | Oral |
| Dosage Form | Compressed tablet |
| Pharmacological Action | Stimulates erythropoiesis |
| Therapeutic Indication | Anemia caused by deficient red-cell production |
| Mechanism of Activity | Androgen receptor agonist |
| Melting Point | 172–180 °C |
| Solubility Profile | Low solubility in water |
| Physical Appearance | White to pale-yellow crystalline solid |
| Half-Life Duration | Approx 8–9 hours |
| Metabolic Location | Hepatic metabolism |
| Active Ingredient | Oxymetholone |
| Dosage Strength | 25 mg |
| Drug Category | Anabolic-androgenic steroid |
| Chemical Formula | C21H32O3 |
| Molecular Weight | 332.48 g/mol |
| Chemical Classification | Dihydrotestosterone derivative |
| Administration Route | Oral |
| Dosage Form | Compressed tablet |
| Pharmacological Action | Stimulates erythropoiesis |
| Therapeutic Indication | Anemia caused by deficient red-cell production |
| Mechanism of Activity | Androgen receptor agonist |
| Melting Point | 172–180 °C |
| Solubility Profile | Low solubility in water |
| Physical Appearance | White to pale-yellow crystalline solid |
| Half-Life Duration | Approx 8–9 hours |
| Metabolic Location | Hepatic metabolism |
3316 E Richert AveFresno, CA 93726, USA
GET DIRECTION